Precision dermatology powered by microbial and genetic engineering Developing novel therapeutics to treat adverse skin conditions and disease
Branford, CT
Joined November 2015
- Tweets533
- Following376
- Followers605
- Likes600
Catch our Cofounder and COO, @twhitfill, discuss the company’s development of functional human filaggrin for topical skin care applications.
Watch the full video on Personal Care Insights website: personalcareinsights.com/vid…
$AZTR #SkinBarrier #Dermatology #SkinCare
More from our CEO in our recent announcement - @azitrainc announces advances ATR-04 Phase 1/2 Clinical Trial to Cohort 2 Following Safety Review Committee Clearance.
See here: ir.azitrainc.com/news-releas…
$AZTR #PrecisionDerm #Dermatology #SkinCare #CancerRash #EGFRiRash
ICYMI - Azitra Inc announces advances ATR-04 Phase 1/2 Clinical Trial to Cohort 2 Following Safety Review Committee Clearance.
See the full release here: prnewswire.com/news-releases…
$AZTR #PrecisionDerm #Dermatology #SkinCare #SkinElasticity
@azitrainc platform is designed to engineer beneficial skin bacteria, such as S. epidermidis, to deliver therapeutic proteins and molecules directly to affected skin.
Learn more here: azitrainc.com/technology/
#PrecisionDermatology #SyntheticBiology #Biotech #Dermatology
Be sure to check us out next week at the H.C. Wainwright 28th Annual Global Investment Conference @azitrainc #PrecisionDerm #CancerRash #SkinDisorder #SkinCare #SkinElasticity #Cosmeceuticals $AZTR
ir.azitrainc.com/news-releas…
@azitrainc to Present at the H.C. Wainwright 28th Annual Global Investment Conference #PrecisionDerm #CancerRash #SkinCare #SkinElasticity $AZTR ir.azitrainc.com/news-releas…
#Cancer Therapy-Associated #Rash is a big problem - earliest to occur, most predictable, & most common adverse event of EGFR inhibitors - papulopustular rashes, affecting 60-90% of patients. Learn more here azitrainc.com/pipeline/#ATR-… #CancerRash #PrecisionDerm
More about #filaggrin for #dermatology and #skinhealth - learn more about our ATR-COSF program - supernatant of filaggrin-producing S. epidermidis for #cosmeceuticals. Translating @azitrainc's cutting edge science to potentially benefit consumers
$AZTR
azitrainc.com/pipeline/
ICYMI - @Azitrainc filaggrin ingredient shows anti-wrinkle potential from PersonalCareInsights.com #PrecisionDerm #SkinCare #SkinElasticity $AZTR
Read it here - personalcareinsights.com/new…
More about our ATR-COSF - recombinant filaggrin protein program representing the first consumer-facing expansion of @azitrainc's #SyntheticBiology platform, adapting #PrecisionDermatology technology for the cosmeceutical market $AZTR Read more about it: azitrainc.com/pipeline/#atr-…
More from last week's update - announcing Q2 2026 results & business updates:
ir.azitrainc.com/news-releas…
$AZTR #PrecisionDerm #RareDisease #Dermatology #Cosmeceuticals #SkinBarrier #Skincare
Yesterday we announced Q2 2026 results and business updates - See the release here. ir.azitrainc.com/news-releas…
$AZTR #PrecisionDerm #RareDisease #Dermatology #Cosmeceuticals #SkinBarrier #Skincare
Featured in Personal Care Insights -
@azitrainc explores recombinant filaggrin for post-weight-loss skin firmness $AZTR #SkinCare #SkinElasticity
personalcareinsights.com/new…
Azitra, Inc. retweeted
In an exclusive interview with The Fly, @azitrainc CEO spoke about the company's expanding #strategy, the science behind its recombinant #protein programs and the commercial potential of ATR COSF. More in "Meet the Company," from @theflynews $AZTR thefly.com/AZTR
ICYMI - Personal Care Insights covered our announcement last week - @azitrainc filaggrin ingredient shows #antiwrinkle potential
personalcareinsights.com/new…
$AZTR
#Cosmeceuticals #SkinBarrier #Dermatology #Skincare
Thanks to Personal Care Insights for covering our latest:
Azitra filaggrin ingredient shows anti-wrinkle potential
personalcareinsights.com/new…
$AZTR #Cosmeceuticals #SkinBarrier #Dermatology #Skincare
Check out our latest announcement: Azitra Inc Announces Breakthrough Repeat Dose and Anti-Wrinkle Ex Vivo Results for ATR-COSF Program, Demonstrating Increased Distribution and Elasticity
ir.azitrainc.com/news-releas…
$AZTR #Cosmeceuticals #SkinBarrier #Dermatology #Skincare
Azitra, Inc. retweeted
@azitrainc's co-founder & Chief Operating Officer, Travis Whitfill, outlines the pathway forward for a cosmeceutical in contrast to a pharmaceutical product.
$AZTR
#Cosmeceuticals #SkinBarrier #Filaggrin #Dermatology #SkincareScience #SkinMicrobiome
youtube.com/shorts/NQHPISIW0…
Watch here - @azitrainc Co-Founder & Chief Operating Officer, Travis Whitfill speaking to Unboxing Biotech - about the company's #cosmetics program & updates on the status of the ATR-01, ATR-04 & ATR-12 programs. #PrecisionDerm #biotech #skincare $AZTR youtube.com/watch?v=NX7RZdbh…
About ATR-04 an investigational live biotherapeutic for EGFR inhibitor ("EGFRi") associated rash. @azitrainc has received Fast Track designation from the FDA for EGFRi associated rash, which impacts approximately 150,000 people in the U.S.
More here: azitrainc.com/pipeline/#ATR-…
